Naltrexone dose-selectively modulates goal-directed behavior and the hypothalamic proteome in rats

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Naltrexone, an opioid receptor antagonist, modulates reward processing.
• The dose-dependent effects of naltrexone on motivation are not well understood.
• This study explores naltrexone's impact on motivation and its underlying mechanisms.

Purpose of the Study:

• To investigate how different doses of naltrexone affect behavioral measures of motivation in rats.
• To explore potential neurobiological mechanisms, including the proopiomelanocortin (POMC) pathway.
• To determine if naltrexone influences motivational vigor, directedness, and effort-based decision-making.

Main Methods:

• Male Sprague Dawley rats were administered naltrexone (0.01, 0.1, or 1 mg/kg) for two weeks.
• Behavioral testing included progressive ratio (PR) and effort-based choice (EBC) schedules.
• Hypothalami were analyzed using data-independent acquisition (DIA) for proteomic changes.

Main Results:

• Low-dose naltrexone (LDN) transiently increased PR response vigor.
• An intermediate dose (0.1 mg/kg) impaired effort-based decision-making and goal-directedness.
• Proteomic analysis revealed dose-dependent alterations in growth hormone and G protein-coupled receptor signaling pathways.

Conclusions:

• Naltrexone exhibits dose-specific effects on motivation and hypothalamic proteome.
• Intermediate naltrexone doses impair motivational directedness and decision-making.
• Motivational effects of naltrexone do not involve the POMC pathway, suggesting alternative mechanisms.